Catawba Research
Private Company
Funding information not available
Overview
Catawba Research is a well-established, private CRO with nearly four decades of experience managing complex clinical trials. It leverages a nimble, client-tailored approach ('The Catawba Way') and deep scientific leadership to guide sponsors from early clinical programs to market authorization. Recent strategic moves, including a partnership with PharmaLegacy Laboratories and the establishment of Catawba Research India, demonstrate an expansion of its end-to-end service capabilities and global footprint, particularly in the Asia-Pacific region. The company positions itself as a trusted partner for sponsors seeking efficient, high-quality trial execution.
Technology Platform
Integrated clinical trial service delivery platform ('The Catawba Way') emphasizing agile project management, active scientific leadership, regulatory-compliant quality systems, and global data management capabilities.
Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global CRO market, competing against large full-service players (e.g., IQVIA, ICON) and numerous niche CROs. Differentiates through its agile, client-tailored approach ('The Catawba Way'), deep experience in specific sectors like infectious disease, and expertise in complex regulatory pathways such as 505(b)(2).